tetano
Editor, Senior Moderator
Front Immunol
. 2020 Nov 13;11:595970.
doi: 10.3389/fimmu.2020.595970. eCollection 2020.
Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis
Li Zhang[SUP] 1 [/SUP], Binyang Zheng[SUP] 1 [/SUP], Xingsu Gao[SUP] 1 [/SUP], Libo Zhang[SUP] 2 [/SUP], Hongxin Pan[SUP] 1 [/SUP], Yong Qiao[SUP] 3 [/SUP], Guangli Suo[SUP] 3 [/SUP], Fengcai Zhu[SUP] 1 [/SUP]
Affiliations
Abstract
The pandemic caused by emerging Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) presents a global public health threat. Illustrating human antibody responding to viral antigen could potentially provide valuable information for basic research and clinical diagnosis. The antibody can be used as a complement to the viral detection for the rapid diagnosis of infected patients. Compared with spike protein (SP), nucleocapsid protein (NP) is normally conserved and highly immunogenic in many coronavirus members. As a major antigen, NP is a potential target for the diagnosis of SARS-CoV-2 infection. Here, we constructed a combinatorial fragment of antigen-binding (Fab)antibody phage library based on peripheral blood-derived from five coronavirus disease 2019 (COVID-19) infected donors. From the library, 159 Fab antibodies were obtained and identified by panning with NP. Among them, 16 antibodies were evaluated for their binding properties and epitopes recognition. Among these 16 antibodies, two well-paired antibodies were finally screened out for SARS-CoV-2 diagnosis by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) method. Our works may provide a potential resource for the clinical diagnosis of SARS-CoV-2 infection.
Keywords: SARS-CoV-2; human antibody; nucleocapsid protein; phage display; sandwich ELISA.
. 2020 Nov 13;11:595970.
doi: 10.3389/fimmu.2020.595970. eCollection 2020.
Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis
Li Zhang[SUP] 1 [/SUP], Binyang Zheng[SUP] 1 [/SUP], Xingsu Gao[SUP] 1 [/SUP], Libo Zhang[SUP] 2 [/SUP], Hongxin Pan[SUP] 1 [/SUP], Yong Qiao[SUP] 3 [/SUP], Guangli Suo[SUP] 3 [/SUP], Fengcai Zhu[SUP] 1 [/SUP]
Affiliations
- PMID: 33281824
- PMCID: PMC7691652
- DOI: 10.3389/fimmu.2020.595970
Abstract
The pandemic caused by emerging Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) presents a global public health threat. Illustrating human antibody responding to viral antigen could potentially provide valuable information for basic research and clinical diagnosis. The antibody can be used as a complement to the viral detection for the rapid diagnosis of infected patients. Compared with spike protein (SP), nucleocapsid protein (NP) is normally conserved and highly immunogenic in many coronavirus members. As a major antigen, NP is a potential target for the diagnosis of SARS-CoV-2 infection. Here, we constructed a combinatorial fragment of antigen-binding (Fab)antibody phage library based on peripheral blood-derived from five coronavirus disease 2019 (COVID-19) infected donors. From the library, 159 Fab antibodies were obtained and identified by panning with NP. Among them, 16 antibodies were evaluated for their binding properties and epitopes recognition. Among these 16 antibodies, two well-paired antibodies were finally screened out for SARS-CoV-2 diagnosis by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) method. Our works may provide a potential resource for the clinical diagnosis of SARS-CoV-2 infection.
Keywords: SARS-CoV-2; human antibody; nucleocapsid protein; phage display; sandwich ELISA.